Your browser doesn't support javascript.
loading
HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR.
Sakai, Kazuya; Kuwana, Masataka; Tanaka, Hidenori; Hosomichi, Kazuyoshi; Hasegawa, Atsushi; Uyama, Hiroki; Nishio, Kenji; Omae, Takashi; Hishizawa, Masakatsu; Matsui, Masashi; Iwato, Koji; Okamoto, Akinao; Okuhiro, Kazuki; Yamashita, Yukiko; Itoh, Masataka; Kumekawa, Hanae; Takezako, Naoki; Kawano, Noriaki; Matsukawa, Toshihiro; Sano, Haruna; Ohshiro, Kazuiku; Hayashi, Kunio; Ueda, Yasunori; Mushino, Toshiki; Ogawa, Yoshiyuki; Yamada, Yuji; Murata, Mitsuru; Matsumoto, Masanori.
  • Sakai K; Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan.
  • Kuwana M; Department of Allergy and Rheumatology, Nippon Medical School, Tokyo, Japan.
  • Tanaka H; HLA Foundation Laboratory, Kyoto, Japan.
  • Hosomichi K; Department of Bioinformatics and Genomics Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Hasegawa A; Department of Hematology.
  • Uyama H; Department of Respiratory Medicine.
  • Nishio K; Department of General Internal Medicine, and.
  • Omae T; Department of Pediatrics, Nara Medical University, Kashihara, Japan.
  • Hishizawa M; Department of Hematology and Oncology, Kyoto University, Kyoto, Japan.
  • Matsui M; Department of Hematology, Kyoto City Hospital, Kyoto, Japan.
  • Iwato K; Department of Hematology, Hiroshima Red Cross Hospital, Hiroshima, Japan.
  • Okamoto A; Department of Hematology, Fujita Health University, Toyoake, Japan.
  • Okuhiro K; Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
  • Yamashita Y; Department of Hematology and Oncology, Ashiya Municipal Hospital, Ashiya, Japan.
  • Itoh M; Department of Pediatrics, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
  • Kumekawa H; Department of Hematology, Tokyo Teishin Hospital, Tokyo, Japan.
  • Takezako N; Department of Hematology, National Disaster Medical Hospital, Tachikawa, Japan.
  • Kawano N; Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan.
  • Matsukawa T; Department of Internal Medicine, Kushiro Rosai Hospital, Kushiro, Japan.
  • Sano H; Department of Hematology, Saga-ken Medical Centre Koseikan, Saga, Japan.
  • Ohshiro K; Department of Hematology, Okinawa Prefectural Nanbu Medical Center and Child Medical Center, Okinawa, Japan.
  • Hayashi K; Department of Hematology, Meiwa Hospital, Nishinomiya, Japan.
  • Ueda Y; Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Mushino T; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
  • Ogawa Y; Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Yamada Y; Department of General Internal Medicine, Saitama Medical University, Moroyamamachi, Japan; and.
  • Murata M; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Matsumoto M; Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan.
Blood ; 135(26): 2413-2419, 2020 06 25.
Article en En | MEDLINE | ID: mdl-32253422
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare autoimmune disorder caused by neutralizing anti-ADAMTS13 autoantibodies. In white individuals, HLA allele DRB1*11 is a predisposing factor for iTTP, whereas DRB1*04 is a protective factor. However, the role of HLA in Asians is unclear. In this study, we analyzed 10 HLA loci using next-generation sequencing in 52 Japanese patients with iTTP, and the allele frequency in the iTTP group was compared with that in a Japanese control group. We identified the following HLA alleles as predisposing factors for iTTP in the Japanese population: DRB1*08:03 (odds ratio [OR], 3.06; corrected P [Pc] = .005), DRB3/4/5*blank (OR, 2.3; Pc = .007), DQA1*01:03 (OR, 2.25; Pc = .006), and DQB1*06:01 (OR,: 2.41; Pc = .003). The estimated haplotype consisting of these 4 alleles was significantly more frequent in the iTTP group than in the control group (30.8% vs 6.0%; Pc < .001). DRB1*15:01 and DRB5*01:01 were weak protective factors for iTTP (OR, 0.23; Pc = .076; and OR, 0.23, Pc = .034, respectively). On the other hand, DRB1*11 and DRB1*04 were not associated with iTTP in the Japanese. These findings indicated that predisposing and protective factors for iTTP differ between Japanese and white individuals. HLA-DR molecules encoded by DRB1*08:03 and DRB1*11:01 have different peptide-binding motifs, but interestingly, bound to the shared ADAMTS13 peptide in an in silico prediction model.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Púrpura Trombocitopénica Trombótica / Antígenos HLA-DR / Pueblo Asiatico / Proteína ADAMTS13 Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male País como asunto: Asia Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Púrpura Trombocitopénica Trombótica / Antígenos HLA-DR / Pueblo Asiatico / Proteína ADAMTS13 Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male País como asunto: Asia Idioma: En Año: 2020 Tipo del documento: Article